Literature DB >> 36134831

The effects of thymoquinone on pancreatic cancer and immune cells.

Celal Alandağ1, Derya Dilek Kancaği2, Gözde Karakuş Sir2, Didem Çakirsoy2, Ercüment Ovali2, Elanur Karaman3, Elif Yüce4, Feyyaz Özdemir5.   

Abstract

OBJECTIVES: Black cumin is widely used as a spice and as a traditional treatment. The active ingredient in black cumin seeds is thymoquinone. Thymoquinone has shown anticancer effects in some cancers. We planned to investigate its anticancer effect on pancreatic cancer cell lines.
METHODS: Thymoquinone chemical component in various doses was prepared and inoculated on pancreatic cancer cell culture, healthy mesenchymal stem cells, and peripheral blood mononuclear cell culture. IC50 values were calculated by absorbance data and measuring cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide staining of cells incubated with thymoquinone at 24, 48, and 72 h.
RESULTS: There was dose-related cytotoxicity. Maximal cytotoxicity was observed at 24 h and 100 μM thymoquinone concentrations in pancreatic cancer cell culture and mesenchymal stem cells. Any concentration of thymoquinone was not cytotoxic to peripheral blood mononuclear cell. Thymoquinone even caused proliferation at a concentration of 6.25 μM.
CONCLUSIONS: Since the cytotoxic concentration of thymoquinone on pancreatic cancer cell culture and mesenchymal stem cells is the same, it is not appropriate to use thymoquinone to achieve cytotoxicity in pancreatic cancer. However, since thymoquinone provides proliferation in peripheral blood mononuclear cell at a noncytotoxic dose, it may have an immune activator effect. Therefore, in vivo studies are needed to investigate the effect of thymoquinone on the immune system.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36134831      PMCID: PMC9574985          DOI: 10.1590/1806-9282.20220066

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


  11 in total

Review 1.  Thymoquinone: potential cure for inflammatory disorders and cancer.

Authors:  Chern Chiuh Woo; Alan Prem Kumar; Gautam Sethi; Kwong Huat Benny Tan
Journal:  Biochem Pharmacol       Date:  2011-10-10       Impact factor: 5.858

2.  Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines.

Authors:  Sara Rooney; M F Ryan
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

3.  Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture.

Authors:  Mary Tan; Anne Norwood; Merilyn May; Michelle Tucci; Hamed Benghuzzi
Journal:  Biomed Sci Instrum       Date:  2006

4.  Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.

Authors:  Gang-Gang Mu; Ling-Li Zhang; Hong-Yan Li; Yan Liao; Hong-Gang Yu
Journal:  Dig Dis Sci       Date:  2014-10-26       Impact factor: 3.199

5.  Immunomodulatory effect of Nigella sativa proteins fractionated by ion exchange chromatography.

Authors:  A Haq; P I Lobo; M Al-Tufail; N R Rama; S T Al-Sedairy
Journal:  Int J Immunopharmacol       Date:  1999-04

6.  Nigella sativa: effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity.

Authors:  A Haq; M Abdullatif; P I Lobo; K S Khabar; K V Sheth; S T al-Sedairy
Journal:  Immunopharmacology       Date:  1995-08

Review 7.  Thymoquinone: A novel strategy to combat cancer: A review.

Authors:  Muhammad Imran; Abdur Rauf; Imtiaz Ali Khan; Muhammad Shahbaz; Tahira Batool Qaisrani; Sri Fatmawati; Tareq Abu-Izneid; Ali Imran; Khaliq Ur Rahman; Tanweer Aslam Gondal
Journal:  Biomed Pharmacother       Date:  2018-07-11       Impact factor: 6.529

8.  Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants.

Authors:  H Zubair; H Y Khan; A Sohail; S Azim; M F Ullah; A Ahmad; F H Sarkar; S M Hadi
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

9.  Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets.

Authors:  Emily M Murphy; Connor S Centner; Paula J Bates; Mohammad T Malik; Jonathan A Kopechek
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 10.  Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells.

Authors:  Zaynab Fatfat; Maamoun Fatfat; Hala Gali-Muhtasib
Journal:  World J Clin Oncol       Date:  2021-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.